Prioritizing VELDONA®'s development for oral warts in HIV+ patients and Sjogren's syndromeBurgeoning pet care market also presents growth opportunities for VELDONA® SAN DIEGO, CA / ACCESSWIRE / Octobe ...
After 68 clinical studies across 16 indications with approximately 6,000 trial participants, VELDONA® demonstrated a strong safety profile compared to injectable versions, with notable clinical ...